Literature DB >> 16169638

Influenza vaccination coverage and reasons to refrain among high-risk persons in four European countries.

Madelon Kroneman1, Gerrit A van Essen, W John Paget.   

Abstract

This paper examines influenza vaccine coverage using a population base of an average of 2300 persons in each of four European countries (Germany, Spain, Poland and Sweden). The reasons for non-vaccination of those in the high-risk groups were explored by questionnaire. The vaccine coverage rate (VCR) for elderly ranged from 18% in Poland to 67% in Spain. The VCR for high-risk population under 65 was 10% in Poland, 13% in Sweden, 27% in Germany and 30% in Spain. The most important reasons mentioned for not being vaccinated were: perceived sufficient resistance to flu (33-42%) in all countries; financial barriers in Poland (25%), and not to qualify for the vaccination (30%) and forgetfulness (20%) in Germany. Receiving a personal invitation for the vaccination, results in higher coverage rates in all four countries. We think that future interventions could be directed towards: an information campaign with special attention to the high-risk groups due to disease; promotion of personal invitations; and, for Poland, solving financial barriers to vaccination.

Entities:  

Mesh:

Year:  2005        PMID: 16169638     DOI: 10.1016/j.vaccine.2005.08.040

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  34 in total

1.  [Flu vaccination in Spain: we still have not improved].

Authors:  Antonio Sarría-Santamera; María Sandín-Vázquez
Journal:  Aten Primaria       Date:  2006-12       Impact factor: 1.137

2.  Influenza vaccination coverage rates in Austria in 2006/07 - a representative cross-sectional telephone survey.

Authors:  Patricia R Blank; Andreas U Freiburghaus; Matthias M Schwenkglenks; Thomas D Szucs; Ursula Kunze
Journal:  Wien Med Wochenschr       Date:  2008

3.  Influenza vaccination coverage among high-risk groups in 11 European countries.

Authors:  Adrian Loerbroks; Christian Stock; Jos A Bosch; David G Litaker; Christian J Apfelbacher
Journal:  Eur J Public Health       Date:  2011-07-12       Impact factor: 3.367

4.  Impact of pharmacist administration of influenza vaccines on uptake in Canada.

Authors:  Sarah A Buchan; Laura C Rosella; Michael Finkelstein; David Juurlink; Jennifer Isenor; Fawziah Marra; Anik Patel; Margaret L Russell; Susan Quach; Nancy Waite; Jeffrey C Kwong
Journal:  CMAJ       Date:  2016-08-08       Impact factor: 8.262

5.  Implementing an influenza vaccination programme for adults aged ≥65 years in Poland: a cost-effectiveness analysis.

Authors:  Lidia Brydak; Julie Roiz; Pascaline Faivre; Camille Reygrobellet
Journal:  Clin Drug Investig       Date:  2012-02-01       Impact factor: 2.859

6.  Vaccine hesitancy in Austria : A cross-sectional survey.

Authors:  Michael J Sandhofer; Oliver Robak; Herbert Frank; Johannes Kulnig
Journal:  Wien Klin Wochenschr       Date:  2016-08-26       Impact factor: 1.704

7.  Disparities in influenza vaccination coverage rates by target group in five European countries: trends over seven consecutive seasons.

Authors:  P R Blank; M Schwenkglenks; T D Szucs
Journal:  Infection       Date:  2009-09-18       Impact factor: 3.553

8.  Safety and immunogenicity of two influenza virus subunit vaccines, with or without MF59 adjuvant, administered to human immunodeficiency virus type 1-seropositive and -seronegative adults.

Authors:  P Durando; D Fenoglio; A Boschini; F Ansaldi; G Icardi; L Sticchi; A Renzoni; P Fabbri; A Ferrera; A Parodi; B Bruzzone; G Gabutti; A Podda; G Del Giudice; E Fragapane; F Indiveri; P Crovari; R Gasparini
Journal:  Clin Vaccine Immunol       Date:  2007-11-14

9.  Vaccination coverage of children with rare genetic diseases and attitudes of their parents toward vaccines.

Authors:  Susanna Esposito; Marta Cerutti; Donatella Milani; Francesca Menni; Nicola Principi
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

10.  Influenza vaccination coverage rates among diabetes sufferers, predictors of adherence and time trends from 2003 to 2010 in Spain.

Authors:  Isabel Jimenez-Trujillo; Ana López-de Andrés; Valentín Hernández-Barrera; Pilar Carrasco-Garrido; Juana María Santos-Sancho; Rodrigo Jiménez-García
Journal:  Hum Vaccin Immunother       Date:  2013-02-12       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.